Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Moodys
Express Scripts
Medtronic
AstraZeneca
Baxter
Colorcon

Last Updated: May 19, 2022

CLINICAL TRIALS PROFILE FOR COSOPT PF


✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for Cosopt Pf

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00140049 ↗ A 12week, Randomized, Evaluator-Masked, Parallel Group Comparing Evening Dosing Of Xalacom Vs Cosopt In Subj W/ Glaucoma Completed Pfizer Phase 4 2005-07-01 To demonstrate the statistical non inferiority of the combination of latanoprost and timolol given in the evening time once a day vs the combination of dorzamalide and timolol twice a day based on intraocular pressure measurements at 8 AM, 12 noon & 4 PM during a 12 week treatment.
NCT00140049 ↗ A 12week, Randomized, Evaluator-Masked, Parallel Group Comparing Evening Dosing Of Xalacom Vs Cosopt In Subj W/ Glaucoma Completed Pfizer's Upjohn has merged with Mylan to form Viatris Inc. Phase 4 2005-07-01 To demonstrate the statistical non inferiority of the combination of latanoprost and timolol given in the evening time once a day vs the combination of dorzamalide and timolol twice a day based on intraocular pressure measurements at 8 AM, 12 noon & 4 PM during a 12 week treatment.
NCT00273429 ↗ Cosopt Versus Xalatan Completed Pharmaceutical Research Network Phase 4 2005-04-01 To compare the 24-hour efficacy and safety, measured every three hours, of the dorzolamide/timolol fixed combination given twice daily versus latanoprost and placebo each given once daily.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Cosopt Pf

Condition Name

Condition Name for Cosopt Pf
Intervention Trials
Ocular Hypertension 19
Glaucoma 15
Open-Angle Glaucoma 10
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Cosopt Pf
Intervention Trials
Glaucoma 27
Ocular Hypertension 20
Hypertension 15
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Cosopt Pf

Trials by Country

Trials by Country for Cosopt Pf
Location Trials
United States 23
Canada 4
Greece 3
Mexico 2
Italy 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Cosopt Pf
Location Trials
Pennsylvania 3
Massachusetts 3
Michigan 2
Indiana 2
Texas 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Cosopt Pf

Clinical Trial Phase

Clinical Trial Phase for Cosopt Pf
Clinical Trial Phase Trials
Phase 4 18
Phase 3 5
Phase 2/Phase 3 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Cosopt Pf
Clinical Trial Phase Trials
Completed 28
Unknown status 4
Terminated 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Cosopt Pf

Sponsor Name

Sponsor Name for Cosopt Pf
Sponsor Trials
Alcon Research 9
Merck Sharp & Dohme Corp. 6
Pharmaceutical Research Network 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Cosopt Pf
Sponsor Trials
Other 24
Industry 23
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Colorcon
Moodys
Dow
Medtronic
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.